BlackRock Fund Advisors - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2016$16,241,000
-0.4%
4,587,716
+13.7%
0.00%0.0%
Q3 2016$16,302,000
-1.4%
4,035,089
+7.1%
0.00%
-25.0%
Q2 2016$16,539,000
+21.5%
3,767,356
+4.6%
0.00%
+33.3%
Q1 2016$13,609,000
-75.8%
3,600,323
+0.4%
0.00%
-76.9%
Q4 2015$56,221,000
+41.8%
3,585,519
-4.7%
0.01%
+30.0%
Q3 2015$39,651,000
-56.8%
3,761,916
+3.4%
0.01%
-54.5%
Q2 2015$91,796,000
-11.4%
3,639,813
-2.1%
0.02%
-12.0%
Q1 2015$103,645,000
+69.9%
3,718,889
+11.3%
0.02%
+66.7%
Q4 2014$60,986,000
+55.1%
3,341,726
+10.1%
0.02%
+36.4%
Q3 2014$39,324,000
-21.2%
3,034,230
-0.8%
0.01%
-21.4%
Q2 2014$49,902,000
-15.7%
3,057,751
-8.7%
0.01%
-22.2%
Q1 2014$59,195,000
-22.4%
3,350,054
+6.4%
0.02%
-21.7%
Q4 2013$76,235,000
-27.9%
3,148,910
+5.5%
0.02%
-36.1%
Q3 2013$105,790,000
+160.5%
2,985,877
+14.8%
0.04%
+140.0%
Q2 2013$40,616,0002,601,9250.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,006$16,957,000100.00%
Meditor Group Ltd 5,800,000$14,326,0002.16%
TSP Capital Management Group, LLC 1,135,748$2,805,0001.29%
COLUMBIA WANGER ASSET MANAGEMENT LLC 8,526,619$21,061,0000.30%
Marcus Capital, LLC 103,800$256,0000.22%
Benchmark Capital Advisors 64,800$160,0000.13%
Vident Investment Advisory, LLC 480,018$1,186,0000.10%
Bellevue Group AG 160,000$395,0000.05%
NJ State Employees Deferred Compensation Plan 100,000$247,0000.05%
Virtus ETF Advisers LLC 126,989$314,0000.05%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders